国际脑血管病杂志
國際腦血管病雜誌
국제뇌혈관병잡지
INTERNATIONAL JOURNAL OF CEREBROVASCULAR DISEASES
2011年
11期
811-817
,共7页
李永坤%殷勤%朱武生%汪银洲%刘德志%陈茂刚%徐格林%刘新峰
李永坤%慇勤%硃武生%汪銀洲%劉德誌%陳茂剛%徐格林%劉新峰
리영곤%은근%주무생%왕은주%류덕지%진무강%서격림%류신봉
锁骨下动脉窃血综合征%动脉闭塞性疾病%动脉粥样硬化%支架%治疗结果
鎖骨下動脈竊血綜閤徵%動脈閉塞性疾病%動脈粥樣硬化%支架%治療結果
쇄골하동맥절혈종합정%동맥폐새성질병%동맥죽양경화%지가%치료결과
Subclavian steal syndrome%Arterial occlusive diseases%Atherosclerosis%Stents%Treatment outcome
目的 探讨血管内支架治疗合并其他头颈动脉狭窄(other craniocervical artery stenoses,OCAS)的粥样硬化性锁骨下动脉狭窄闭塞性病变(subclavian artery stenosis-occlusion,SASO)患者的疗效.方法 回顾性分析接受血管内支架治疗的粥样硬化性SASO患者的临床资料,包括人口统计学特征、血管危险因素、合并OCAS情况以及SASO支架治疗和随访结果.结果 共纳入65例SASO患者,其中男性47例,女性18例,平均年龄(64±9)岁,46例(70.8％)合并OCAS.总的技术成功率为95.4％,其中狭窄患者58例(98.1％),完全闭塞患者7例(71.4％).共有4例发生并发症,无介入相关的严重卒中和死亡.平均随访(24±19)个月,发现再狭窄6例和临床相关事件10例,主要发生于合并OCAS的患者.术后12、24个月和随访结束时首次血管成形通畅率分别为94.5％、81.8％和81.8％,无临床相关事件存活率分别为92.9％、74.6％和68.3％.结论 血管内支架可安全和有效地治疗合并OCAS的SASO患者,其总体临床转归在一定程度上受OCAS的影响.
目的 探討血管內支架治療閤併其他頭頸動脈狹窄(other craniocervical artery stenoses,OCAS)的粥樣硬化性鎖骨下動脈狹窄閉塞性病變(subclavian artery stenosis-occlusion,SASO)患者的療效.方法 迴顧性分析接受血管內支架治療的粥樣硬化性SASO患者的臨床資料,包括人口統計學特徵、血管危險因素、閤併OCAS情況以及SASO支架治療和隨訪結果.結果 共納入65例SASO患者,其中男性47例,女性18例,平均年齡(64±9)歲,46例(70.8％)閤併OCAS.總的技術成功率為95.4％,其中狹窄患者58例(98.1％),完全閉塞患者7例(71.4％).共有4例髮生併髮癥,無介入相關的嚴重卒中和死亡.平均隨訪(24±19)箇月,髮現再狹窄6例和臨床相關事件10例,主要髮生于閤併OCAS的患者.術後12、24箇月和隨訪結束時首次血管成形通暢率分彆為94.5％、81.8％和81.8％,無臨床相關事件存活率分彆為92.9％、74.6％和68.3％.結論 血管內支架可安全和有效地治療閤併OCAS的SASO患者,其總體臨床轉歸在一定程度上受OCAS的影響.
목적 탐토혈관내지가치료합병기타두경동맥협착(other craniocervical artery stenoses,OCAS)적죽양경화성쇄골하동맥협착폐새성병변(subclavian artery stenosis-occlusion,SASO)환자적료효.방법 회고성분석접수혈관내지가치료적죽양경화성SASO환자적림상자료,포괄인구통계학특정、혈관위험인소、합병OCAS정황이급SASO지가치료화수방결과.결과 공납입65례SASO환자,기중남성47례,녀성18례,평균년령(64±9)세,46례(70.8％)합병OCAS.총적기술성공솔위95.4％,기중협착환자58례(98.1％),완전폐새환자7례(71.4％).공유4례발생병발증,무개입상관적엄중졸중화사망.평균수방(24±19)개월,발현재협착6례화림상상관사건10례,주요발생우합병OCAS적환자.술후12、24개월화수방결속시수차혈관성형통창솔분별위94.5％、81.8％화81.8％,무림상상관사건존활솔분별위92.9％、74.6％화68.3％.결론 혈관내지가가안전화유효지치료합병OCAS적SASO환자,기총체림상전귀재일정정도상수OCAS적영향.
Objective To investigate the efficacy of endovascular stenting complicating other craniocervical artery stenosis (OCAS) in patients with atherosclerotic subclavian artery stenosis/occlusion (SASO).Methods The clinical data of receiving endovascular stenting therapy in patients with atherosclerotic SASO were analyzed retrospectively,including demographic characteristics,vascular risk factors,complicating OCAS,as well as stenting for SASO and follow-up results.Results A total of 65 patients with SASO were included in the study,47 of them were males and 18 were females (mean age of 64 ± 9 years).Forty-six patients (70.8％ ) complicated OCAS.The overall technical success rate was 95.4％,in which the patients with stenosis (n =58) were 98.1％ and those with complete occlusion (n =7) were 71.4％.The complications occurred in 4 patients.There were no intervention-related serious stroke and death.Mean follow-up was 24 ± 19 months,6 patients with restenosis and 10 with clinically relevant events were found.They mainly occurred in patients with OCAS.The first angioplasty patency rates were 94.5％,81.8％ and 81.8％,respectively at 12 and 24 months after procedure and at the end of follow-up.The survival rates of no clinically relevant events were 92.9％,74.6％ and 68.3％,respectively.Conclusions Endovascular stenting can safely and effectively treat the SASO patients complicating OCAS.Its overall clinical outcome may be affected to some extent by OCAS.
